View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Cisplatin 75 / Gemcitabine 1250, Breast Cancer
Protocol-ID: 763 V1.1 (Mini), CISP75/GEMC1250, Breast CaIndication(s)
- Breast Cancer (tripel negative); ICD-10 C50.-
Links
- Efficacy of gemcitabine and cisplatin (GP) as first-line combination therapy in patients with triple-negative metastatic breast cancer: Preliminary results report of a phase II trial. [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 10.01.2023